News

PipelineReview.com6d
Abeona Therapeutics® Announces Option Exercise by Beacon Therapeutics for Novel AAV204 Capsid for Ophthalmology Gene Therapy
Abeona will receive a license payment and potential development, regulatory, and sales milestones, and royalties ...
Ophthalmology Times5d
Beacon Therapeutics exercises option to license Abeona Therapeutics’ AAV204 capsid
AAV204 is a novel adeno-associated virus (AAV) capsid from the AIM capsid library licensed by Abeona from the University of ...